Vaxxilon discovers and develops novel vaccines for infectious diseases based on the scientific insights and research of Prof P Seeberger (Max Planck Society) and G de Libero (University of Basel). Vaxxilon is advancing several candidates using homogeneous, synthetically produced antigens.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2015
  • Number of employees in Switzerland
    1-9
Key business